Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Marsh & McLennan is the global leader in insurance brokerage, commanding a 22% market share and operating in 130+ countries. MMC’s diversified business model, scale, and digital/AI innovation drive ...

Marsh & McLennan Companies (MMC) has been drifting lower this year, with the stock down roughly 14% year to date despite steady revenue and earnings growth, which sets up an interesting valuation ...

Abstract: Similar to the conventional three-phase parallel-connected MMC (PC-MMC), the three-phase series-connected MMC (SC-MMC) is a strong potential solution for high-voltage direct current (HVDC) ...

KUALA LUMPUR: Medical sick certificates issued solely through virtual consultation (teleconsultation), even by registered medical practitioners, are not allowed, says the Malaysian Medical Council ...

We may earn commission from links on this page, but we only recommend products we love. Promise. Listen, I’ll be the first person to tell you that homemade face masks can be a little questionable.

Marsh & McLennan Companies Inc (NYSE:MMC) reported better-than-expected earnings for the third quarter on Thursday. The company posted quarterly earnings of $1.85 per share which beat the analyst ...

Marsh & McLennan (MMC) reported $6.35 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 11.5%. EPS of $1.85 for the same period compares to $1.63 a ...

Marsh & McLennan (MMC) came out with quarterly earnings of $1.85 per share, beating the Zacks Consensus Estimate of $1.79 per share. This compares to earnings of $1.63 per share a year ago. These ...

Insurance broker Marsh & McLennan Companies (NYSE:MMC) on Tuesday announced a change in brand to Marsh, effective January 2026. The new ticker symbol will become MRSH from January 2026. The company’s ...

The latest price target for MARSH & MCLENNAN COS (NYSE:MMC) was reported by Cantor Fitzgerald on January 14, 2026. The analyst firm set a price target for $208.00 expecting MMC to rise to within 12 ...